Despite many interests in use of ROR1 molecule as a target for cancer active therapy, so far it has not been introduced in syngeneic ROR1+ animal model and several studies have commonly used human tumor xenografts model in immunosuppressive microenvironments [23,31]. The gene discussed is ROR1; the disease is cancer.